Dr. Haacke is an original pioneer of the MR angiographic imaging, fast imaging and cardiovascular imaging, and has developed a powerful new method for imaging veins, micro-hemorrhaging and iron called Susceptibility Weighted Imaging (SWI). This work has been extended to quantifying iron content using the technology quantitative susceptibility mapping (QMS). He has focused on studying the role of magnetic field variations in the human body and applying the results to clinical translational research. This work with the development of SWI and QSM offers better diagnosis of neurovascular disease. SWI may in fact become an important biomarker not just for different forms of iron but in investigating the etiology of a number of key diseases such as aging, multiple sclerosis, stroke and trauma. SWI is becoming part of a standard neuroimaging protocol eventually to be run on all neuroimaging cases. Both SWI and QSM are now being used to study stroke, atherosclerosis, Parkinson’s disease and multiple sclerosis (to name a few). Recently, he has developed a new microvascular imaging approach that can visualize vessels as small as 50 microns in size to study the vascular structure of neurodegenerative diseases. Finally, he has create a new rapid, mult-contrast technique referred to as STAGE that can allow up to 15 pieces of information about brain tissue in just 5 minutes, a breakthrough for clinical imaging.